Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferribest-Red Syrup
- Development stage
- Unknown
- Lead developer
- IGP Mediventures
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ferribest-Red Syrup is a consumer nutraceutical supplement developed and marketed by IGP Mediventures. It is formulated as an oral syrup containing a combination of iron and zinc, intended to address nutritional deficiencies. As a dietary supplement, it provides essential minerals required for critical physiological processes, including hemoglobin synthesis for oxygen transport and enzymatic cofactors for immune function and metabolism. The product is positioned as an over-the-counter wellness item rather than a clinical drug candidate in a traditional pharmaceutical pipeline.
- Brand names
- Ferribest-Red Syrup
- Other names
- Ferribest-Red Syrup
Beyond the preview
Go deeper on Ferribest-Red Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ferribest-Red Syrup.